Abstract:Author summary Multiple members in a family can be diagnosed with the same disease. In such families, genetics may be a significant factor in disease risk. However, it remains unclear whether such familial aggregation of disease is likely due to a single highly penetrant rare variant (HPRV), many minimally penetrant common variants, or a combination of the two types of variants. We therefore use recent estimates of SNP heritability and the liability threshold model to estimate the proportion of afflicted families likely to carry a rare, causal variant. We then show that Polygenic Risk Scores (PRS) may be useful for identifying families likely to carry such a rare variant and introduce a related statistic that can be used to select families for sequencing studies trying to identify HPRV. Despite genetics being accepted as the primary cause of familial aggregation for most diseases, it is still unclear whether afflicted families are likely to share a single highly penetrant rare variant, many minimally penetrant common variants, or a combination of the two types of variants. We therefore use recent estimates of SNP heritability and the liability threshold model to estimate the proportion of afflicted families likely to carry a rare, causal variant. We then show that Polygenic Risk Scores (PRS) may be useful for identifying families likely to carry such a rare variant and therefore for prioritizing families to include in sequencing studies with that aim. Specifically, we introduce a new statistic that estimates the proportion of individuals carrying causal rare variants based on the family structure, disease pattern, and PRS of genotyped individuals. Finally, we consider data from the MelaNostrum consortium and show that, despite an estimated PRS heritability of only 0.05 for melanoma, families carrying putative causal variants had a statistically significantly lower PRS, supporting the idea that PRS prioritization may be a useful future tool. However, it will be important to evaluate whether the presence of rare mendelian variants are generally associated with the proposed test statistic or lower PRS in future and larger studies.

Contribution of rare variants to heritability of a disease is much greater than conventionally estimated: modification of allele distribution model

A method to estimate the contribution of rare coding variants to complex trait heritability

Heritability of cancers in Japanese population: Estimation from recent cohort data

Contribution of Common Genetic Variants to Familial Aggregation of Disease and Implications for Sequencing Studies.

Narrowing the gap on heritability of common disease by direct estimation in case-control GWAS

Rare variant contribution to the heritability of coronary artery disease

Rare variant effect estimation and polygenic risk prediction

Estimating the heritability of SARS-CoV-2 susceptibility and COVID-19 severity

Unique roles of rare variants in the genetics of complex diseases in humans

Identifying rare variants using a Bayesian regression approach

Rare and low-frequency variants in human common diseases and other complex traits

Effect of non-normality and low count variants on cross-phenotype association tests in GWAS

Missing genetic diversity impacts variant prioritisation for rare disorders

Robust Methods for Disease-Genotype Association in Genetic Association Studies: Calculate P-values Using Exact Conditional Enumeration instead of Asymptotic Approximations

Pooled Association Tests for Rare Genetic Variants: A Review and Some New Results

Powerful Rare‐Variant Association Analysis of Secondary Phenotypes

The Excess of Carriers in Rare Disorders Suggests a Nonpathogenic Effect for Most Variants of Uncertain Significance

Winner's Curse Correction and Variable Thresholding Improve Performance of Polygenic Risk Modeling Based on Genome-Wide Association Study Summary-Level Data

Prediction and replication from case-control sequencing studies using custom genotyping and additional sequencing

Total Heritability Explained by All Variants in Genome-Wide Association Studies Based on Summary Statistics with Standard Error Estimates

Testing Genetic Association with Rare Variants in Admixed Populations.